カテゴリー： QYResearch, 世界, 医療/バイオ

世界のタンパク質＆ペプチド治療薬市場インサイト及び予測（注射、経口）

◆英語タイトル：Global Protein and Peptide Therapeutics Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX10481）◆商品コード：QY22JLX10481
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、タンパク質＆ペプチド治療薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にタンパク質＆ペプチド治療薬の世界市場のxxx％を占める「注射」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「がん」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
タンパク質＆ペプチド治療薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのタンパク質＆ペプチド治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

タンパク質＆ペプチド治療薬のグローバル主要企業には、Sanofi、Teva、Novo Nordisk、Takeda、Eli Lilly、AstraZeneca、Novartis、AbbVie、Ipsen、Ferring、Merck、The Medicines、J & Jなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

タンパク質＆ペプチド治療薬市場は、種類と用途によって区分されます。世界のタンパク質＆ペプチド治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
注射、経口

【用途別セグメント】
がん、代謝性疾患、中枢神経系、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- タンパク質＆ペプチド治療薬製品概要
- 種類別市場（注射、経口）
- 用途別市場（がん、代謝性疾患、中枢神経系、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のタンパク質＆ペプチド治療薬販売量予測2017-2028
- 世界のタンパク質＆ペプチド治療薬売上予測2017-2028
- タンパク質＆ペプチド治療薬の地域別販売量
- タンパク質＆ペプチド治療薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別タンパク質＆ペプチド治療薬販売量
- 主要メーカー別タンパク質＆ペプチド治療薬売上
- 主要メーカー別タンパク質＆ペプチド治療薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（注射、経口）
- タンパク質＆ペプチド治療薬の種類別販売量
- タンパク質＆ペプチド治療薬の種類別売上
- タンパク質＆ペプチド治療薬の種類別価格
・用途別市場規模（がん、代謝性疾患、中枢神経系、その他）
- タンパク質＆ペプチド治療薬の用途別販売量
- タンパク質＆ペプチド治療薬の用途別売上
- タンパク質＆ペプチド治療薬の用途別価格
・北米市場
- 北米のタンパク質＆ペプチド治療薬市場規模（種類別、用途別）
- 主要国別のタンパク質＆ペプチド治療薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのタンパク質＆ペプチド治療薬市場規模（種類別、用途別）
- 主要国別のタンパク質＆ペプチド治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のタンパク質＆ペプチド治療薬市場規模（種類別、用途別）
- 主要国別のタンパク質＆ペプチド治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のタンパク質＆ペプチド治療薬市場規模（種類別、用途別）
- 主要国別のタンパク質＆ペプチド治療薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのタンパク質＆ペプチド治療薬市場規模（種類別、用途別）
- 主要国別のタンパク質＆ペプチド治療薬市場規模（トルコ、サウジアラビア）
・企業情報
Sanofi、Teva、Novo Nordisk、Takeda、Eli Lilly、AstraZeneca、Novartis、AbbVie、Ipsen、Ferring、Merck、The Medicines、J & J
・産業チェーン及び販売チャネル分析
- タンパク質＆ペプチド治療薬の産業チェーン分析
- タンパク質＆ペプチド治療薬の原材料
- タンパク質＆ペプチド治療薬の生産プロセス
- タンパク質＆ペプチド治療薬の販売及びマーケティング
- タンパク質＆ペプチド治療薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- タンパク質＆ペプチド治療薬の産業動向
- タンパク質＆ペプチド治療薬のマーケットドライバー
- タンパク質＆ペプチド治療薬の課題
- タンパク質＆ペプチド治療薬の阻害要因
・主な調査結果

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
Market Analysis and Insights: Global Protein and Peptide Therapeutics Market
The global Protein and Peptide Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Injection accounting for % of the Protein and Peptide Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period.
China Protein and Peptide Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Protein and Peptide Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Protein and Peptide Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Protein and Peptide Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Protein and Peptide Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Protein and Peptide Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Protein and Peptide Therapeutics market.
Global Protein and Peptide Therapeutics Scope and Market Size
Protein and Peptide Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Protein and Peptide Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Injection
Oral
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Protein and Peptide Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Protein and Peptide Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Protein and Peptide Therapeutics Market Perspective (2017-2028)
2.2 Protein and Peptide Therapeutics Growth Trends by Region
2.2.1 Protein and Peptide Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Protein and Peptide Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Protein and Peptide Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Protein and Peptide Therapeutics Market Dynamics
2.3.1 Protein and Peptide Therapeutics Industry Trends
2.3.2 Protein and Peptide Therapeutics Market Drivers
2.3.3 Protein and Peptide Therapeutics Market Challenges
2.3.4 Protein and Peptide Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein and Peptide Therapeutics Players by Revenue
3.1.1 Global Top Protein and Peptide Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Protein and Peptide Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Protein and Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Protein and Peptide Therapeutics Revenue
3.4 Global Protein and Peptide Therapeutics Market Concentration Ratio
3.4.1 Global Protein and Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein and Peptide Therapeutics Revenue in 2021
3.5 Protein and Peptide Therapeutics Key Players Head office and Area Served
3.6 Key Players Protein and Peptide Therapeutics Product Solution and Service
3.7 Date of Enter into Protein and Peptide Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein and Peptide Therapeutics Breakdown Data by Type
4.1 Global Protein and Peptide Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Protein and Peptide Therapeutics Forecasted Market Size by Type (2023-2028)
5 Protein and Peptide Therapeutics Breakdown Data by Application
5.1 Global Protein and Peptide Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Protein and Peptide Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Protein and Peptide Therapeutics Market Size (2017-2028)
6.2 North America Protein and Peptide Therapeutics Market Size by Type
6.2.1 North America Protein and Peptide Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Protein and Peptide Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Protein and Peptide Therapeutics Market Share by Type (2017-2028)
6.3 North America Protein and Peptide Therapeutics Market Size by Application
6.3.1 North America Protein and Peptide Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Protein and Peptide Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Protein and Peptide Therapeutics Market Share by Application (2017-2028)
6.4 North America Protein and Peptide Therapeutics Market Size by Country
6.4.1 North America Protein and Peptide Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Protein and Peptide Therapeutics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Protein and Peptide Therapeutics Market Size (2017-2028)
7.2 Europe Protein and Peptide Therapeutics Market Size by Type
7.2.1 Europe Protein and Peptide Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Protein and Peptide Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Protein and Peptide Therapeutics Market Share by Type (2017-2028)
7.3 Europe Protein and Peptide Therapeutics Market Size by Application
7.3.1 Europe Protein and Peptide Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Protein and Peptide Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Protein and Peptide Therapeutics Market Share by Application (2017-2028)
7.4 Europe Protein and Peptide Therapeutics Market Size by Country
7.4.1 Europe Protein and Peptide Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Protein and Peptide Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein and Peptide Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Protein and Peptide Therapeutics Market Size by Type
8.2.1 Asia-Pacific Protein and Peptide Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Protein and Peptide Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Protein and Peptide Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Protein and Peptide Therapeutics Market Size by Application
8.3.1 Asia-Pacific Protein and Peptide Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Protein and Peptide Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Protein and Peptide Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Protein and Peptide Therapeutics Market Size by Region
8.4.1 Asia-Pacific Protein and Peptide Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Protein and Peptide Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Protein and Peptide Therapeutics Market Size (2017-2028)
9.2 Latin America Protein and Peptide Therapeutics Market Size by Type
9.2.1 Latin America Protein and Peptide Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Protein and Peptide Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Protein and Peptide Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Protein and Peptide Therapeutics Market Size by Application
9.3.1 Latin America Protein and Peptide Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Protein and Peptide Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Protein and Peptide Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Protein and Peptide Therapeutics Market Size by Country
9.4.1 Latin America Protein and Peptide Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Protein and Peptide Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein and Peptide Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Protein and Peptide Therapeutics Market Size by Type
10.2.1 Middle East & Africa Protein and Peptide Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Protein and Peptide Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Protein and Peptide Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Protein and Peptide Therapeutics Market Size by Application
10.3.1 Middle East & Africa Protein and Peptide Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Protein and Peptide Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Protein and Peptide Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Protein and Peptide Therapeutics Market Size by Country
10.4.1 Middle East & Africa Protein and Peptide Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Protein and Peptide Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Protein and Peptide Therapeutics Introduction
11.1.4 Sanofi Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Protein and Peptide Therapeutics Introduction
11.2.4 Teva Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Protein and Peptide Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.3.5 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Protein and Peptide Therapeutics Introduction
11.4.4 Takeda Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.4.5 Takeda Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Protein and Peptide Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.5.5 Eli Lilly Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Protein and Peptide Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Protein and Peptide Therapeutics Introduction
11.7.4 Novartis Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Protein and Peptide Therapeutics Introduction
11.8.4 AbbVie Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.8.5 AbbVie Recent Developments
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Protein and Peptide Therapeutics Introduction
11.9.4 Ipsen Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.9.5 Ipsen Recent Developments
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Protein and Peptide Therapeutics Introduction
11.10.4 Ferring Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.10.5 Ferring Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Protein and Peptide Therapeutics Introduction
11.11.4 Merck Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.11.5 Merck Recent Developments
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Protein and Peptide Therapeutics Introduction
11.12.4 The Medicines Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.12.5 The Medicines Recent Developments
11.13 J & J
11.13.1 J & J Company Details
11.13.2 J & J Business Overview
11.13.3 J & J Protein and Peptide Therapeutics Introduction
11.13.4 J & J Revenue in Protein and Peptide Therapeutics Business (2017-2022)
11.13.5 J & J Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のタンパク質＆ペプチド治療薬市場インサイト及び予測（注射、経口）(Global Protein and Peptide Therapeutics Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 自動ペプチド合成装置のグローバル市場2023年：全自動型、半自動型、手動型
  • 自動ペプチド連続合成装置のグローバル市場2023年：全自動型、半自動型、手動型
  • 自動ペプチド合成装置の世界市場見通し2023年-2029年
  • 世界のペプチド-薬物複合体市場インサイト及び予測（細胞透過性ペプチド（CPP）、細胞標的ペプチド（CTP））
  • 世界のアジュバントペプチド市場インサイト及び予測（95%以上、98%以上）